<html>
 <body>
  <div class="col-md-12" id="content" style="">
   <div class="hidden" data-drupal-messages-fallback="">
   </div>
   <div class="widget block" id="block-medsites-page-title">
    <h1>
     <span property="schema:name">
      Nausea & Vomiting
     </span>
    </h1>
   </div>
   <div class="widget block" id="block-medsites-content">
    <article about="/commodorecompendium/nausea-vomiting" data-history-node-id="930" role="article" typeof="schema:WebPage">
     <div>
      <div class="field field--name-body field--type-text-with-summary field--label-hidden field__item" property="schema:text">
       <div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
        <p style="border:none; padding:0in">
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <b>
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Nausea & Vomiting – Michael J. Neuss
              </span>
             </span>
            </b>
           </span>
          </span>
         </span>
        </p>
       </div>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             General Approach:
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              VOMIT mnemonic (see below)
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <b>
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Several antiemetics can prolong QT interval (see below).
              </span>
             </span>
            </b>
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              Caution is advised when QTc is prolonged (>450 in men and >470 in women), particularly if hypokalemia, hypomagnesemia, or if taking multiple medications with QT prolonging effects.
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              Consider drug use and withdrawal, medication effects, cardiac ischemia, pregnancy, abdominal pathology, adrenal insufficiency, CNS lesion, anxiety, severe pain
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              Labs: BMP, hepatic functional panel, lactate, amylase/lipase, TSH, cortisol (AM vs cort stim), troponin,
             </span>
            </span>
            <span style="font-size:12.0pt">
             <span style='font-family:"Times New Roman",serif'>
              β
             </span>
            </span>
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              hCG, U/A, UDS
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              EKG (know QT, eval for ischemia), KUB/upright, Small bowel follow-through (SBFT)
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              CT A/P, CNS imaging (CT vs MRI; eval for mets in oncology pts)
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              EGD has limited utility unless mechanical gastric outlet obstruction is suspected
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p>
       </p>
       <table align="left" class="MsoTableGrid" style="width:100.0%; border-collapse:collapse; border:none; margin-left:9px; margin-right:9px" width="100%">
        <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>0</th>
      <th>1</th>
      <th>2</th>
      <th>3</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>VOMIT</td>
      <td>VOMIT</td>
      <td>Etiologies</td>
      <td>Management</td>
    </tr>
    <tr>
      <td>Vestibular &amp; Vertigo</td>
      <td>Labyrinthitis, Vestibular neuritis, Meniere’s disease Cerebellar stroke</td>
      <td>Labyrinthitis, Vestibular neuritis, Meniere’s disease Cerebellar stroke</td>
      <td>- Scopolamine, diphenhydramine - Check for nystagmus, truncal ataxia, focal deficits; consider CNS imaging if high risk - VUMC: consider referral to Pi β Phi for vertigo</td>
    </tr>
    <tr>
      <td>Obstruction</td>
      <td>Adhesions, hernia, volvulus, constipation Gastric outlet obstruction (pyloric stenosis from malignancy or PUD)</td>
      <td>Adhesions, hernia, volvulus, constipation Gastric outlet obstruction (pyloric stenosis from malignancy or PUD)</td>
      <td>- Bowel Obstruction: KUB (about 80% sensitive) vs. CT A/P, Surgical consultation (general surgery at VA and EGS at VUMC) - SBFT – both diagnostic and therapeutic - Bowel rest, NGT (if tolerated/indicated), bowel regimen - Gastric outlet obstruction: Inflammation may respond to acid suppression and NGT to suction - Endoscopic dilation, surgery or stenting</td>
    </tr>
    <tr>
      <td>Motility</td>
      <td>GERD, Gastroparesis, autonomic dysfunction (e.g. in diabetics)</td>
      <td>GERD, Gastroparesis, autonomic dysfunction (e.g. in diabetics)</td>
      <td>- If GERD, trial of PPI and de-escalate to H2 blocker once able - Metoclopramide (caution due to side effects, erythromycin second line) - Consider gastric emptying study (limited sensitivity &amp; specificity ONLY outpt off narcotics) - Consider autonomics evaluation</td>
    </tr>
    <tr>
      <td>Meds</td>
      <td>Antibiotics, SSRI, Opioids cannabinoid hyperemesis</td>
      <td>Antibiotics, SSRI, Opioids cannabinoid hyperemesis</td>
      <td>- UDS, CSMD search - Careful med review - Ondansetron - Cannabinoid hyperemesis syndrome: hot showers cyclically. Stop cannabis</td>
    </tr>
    <tr>
      <td>Inflammation or Infection</td>
      <td>Gastroenteritis, PUD, hepatitis, pyelonephritis, nephrolithiasis, cholecystitis, pancreatitis</td>
      <td>Gastroenteritis, PUD, hepatitis, pyelonephritis, nephrolithiasis, cholecystitis, pancreatitis</td>
      <td>- Ondansetron, other agents acceptable - Treat underlying problem</td>
    </tr>
    <tr>
      <td>Toxins</td>
      <td>Uremia, ketoacidosis, hypercalcemia, chemotherapy</td>
      <td>Uremia, ketoacidosis, hypercalcemia, chemotherapy</td>
      <td>- Ondansetron, others acceptable - Treat underlying problem - Pre-treatment for chemo ( usually part of chemo order sets)</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
  </tbody>
</table>
       </table>
       <table align="center" class="MsoTableGrid" style="width:100.0%; border-collapse:collapse; border:none" width="100%">
        <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>0</th>
      <th>1</th>
      <th>2</th>
      <th>3</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Anti-Emetics</td>
      <td>Anti-Emetics</td>
      <td>Anti-Emetics</td>
      <td>Anti-Emetics</td>
    </tr>
    <tr>
      <td>Med (by class)</td>
      <td>Dose</td>
      <td>Side effects?</td>
      <td>QT?</td>
    </tr>
    <tr>
      <td>Serotonin antagonists</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>Ondansetron (Zofran)</td>
      <td>4-8mg PO/IV q6h</td>
      <td>Constipation, headache</td>
      <td>++</td>
    </tr>
    <tr>
      <td>Granisetron (Kytril)1</td>
      <td>2 mg PO x1, 1 mg PO BID pre-chemo, daily patch, OR 10mcg/kg pre-chemo</td>
      <td>‘’</td>
      <td>++</td>
    </tr>
    <tr>
      <td>Dopamine antagonists</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>Prochlorperazine (Compazine)</td>
      <td>5-10 mg PO q6h, 2.5 – 10 mg IV q6h, 25 mg PR q6h</td>
      <td>EPS, less sedation than anti-H</td>
      <td>+</td>
    </tr>
    <tr>
      <td>Haloperidol (Haldol)</td>
      <td>0.5-1 mg PO/IV q6h</td>
      <td>‘’</td>
      <td>++</td>
    </tr>
    <tr>
      <td>Zyprexa (Olanzapine)2</td>
      <td>2.5-10mg PO q6H</td>
      <td>‘’</td>
      <td>+</td>
    </tr>
    <tr>
      <td>Metoclopramide (Reglan)</td>
      <td>10 mg PO/IV q6h</td>
      <td>EPS, dystonia, tardive dyskinesia</td>
      <td>+</td>
    </tr>
    <tr>
      <td>GABAergic</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>Lorazepam (Ativan)</td>
      <td>0.5-2mg PO; 0.25 – 1 mg IV q6h</td>
      <td>Sedation, delirium</td>
      <td>-</td>
    </tr>
    <tr>
      <td>Antihistamines</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>Promethazine (Phenergan)</td>
      <td>12.5 - 25mg PO/IV q6h OR 25 mg PR q6h</td>
      <td>Sedation, EPS (DA antagonist as well)</td>
      <td>+</td>
    </tr>
    <tr>
      <td>Diphenhydramine (Benadryl)</td>
      <td>25-50mg PO/IV q6h</td>
      <td>Sedation, delirium, urinary retention, ileus</td>
      <td>-</td>
    </tr>
    <tr>
      <td>Meclizine (Antivert)</td>
      <td>25 – 50 mg PO qday</td>
      <td>‘’</td>
      <td>-</td>
    </tr>
    <tr>
      <td>Anticholinergics</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>Scopolamine (Hyoscine)</td>
      <td>1.5 mg patch q3day</td>
      <td>‘’</td>
      <td>-</td>
    </tr>
    <tr>
      <td>Other</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>Dexamethasone (Decadron)3</td>
      <td>20 mg PO or IV for CINV; can give with Ondansetron 8-18 mg or Granisetron 10mcg/kg IV or 2 mg PO if high severity CINV</td>
      <td>Hyperglycemia, fluid retention</td>
      <td>-</td>
    </tr>
  </tbody>
</table>
       </table>
       <p>
       </p>
      </div>
     </div>
    </article>
   </div>
  </div>
 </body>
</html>